Mutual of America Capital Management LLC Has $2.37 Million Holdings in The Clorox Company (NYSE:CLX)

Mutual of America Capital Management LLC cut its holdings in shares of The Clorox Company (NYSE:CLX) by 4.2% in the fourth quarter, HoldingsChannel reports. The fund owned 16,649 shares of the company’s stock after selling 734 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Clorox were worth $2,374,000 as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. International Assets Investment Management LLC boosted its position in Clorox by 17,658.5% during the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares during the period. Adage Capital Partners GP L.L.C. acquired a new stake in shares of Clorox during the 3rd quarter valued at about $6,605,000. Eagle Rock Investment Company LLC acquired a new stake in shares of Clorox during the 4th quarter valued at about $2,940,000. Nordea Investment Management AB lifted its holdings in shares of Clorox by 4.0% during the 4th quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock valued at $1,362,000 after buying an additional 364 shares during the last quarter. Finally, Teacher Retirement System of Texas lifted its holdings in shares of Clorox by 742.8% during the 3rd quarter. Teacher Retirement System of Texas now owns 78,713 shares of the company’s stock valued at $10,316,000 after buying an additional 69,373 shares during the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Performance

Shares of NYSE CLX opened at $143.58 on Friday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The business’s 50 day moving average is $149.99 and its two-hundred day moving average is $141.79. The company has a market cap of $17.82 billion, a P/E ratio of 227.90, a P/E/G ratio of 2.22 and a beta of 0.43. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $178.21.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, February 1st. The company reported $2.16 EPS for the quarter, topping the consensus estimate of $1.08 by $1.08. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The company’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.98 EPS. On average, equities analysts expect that The Clorox Company will post 5.52 EPS for the current year.

Clorox Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a $1.20 dividend. This represents a $4.80 annualized dividend and a yield of 3.34%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio is currently 761.90%.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Deutsche Bank Aktiengesellschaft reduced their price target on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday. Barclays reduced their price target on Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a report on Wednesday, April 10th. The Goldman Sachs Group assumed coverage on Clorox in a report on Friday, March 1st. They set a “sell” rating and a $140.00 price target for the company. UBS Group lifted their price target on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, February 2nd. Finally, Morgan Stanley restated an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. Four analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $148.63.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.